Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tizanidine for Pain and Function After Shoulder Arthroscopy
NCT05852093Phase 1Not yet recruiting
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Jun 2023
- Primary completion
- Jun 2026
- Modality
- Small Molecules
01
Overview
Phase 1, randomised trial of tizanidine in rotator cuff tear (2 arms), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Primary endpoint: Pittsburgh Sleep Quality Index at 24 weeks. Planned start Jun 2023; status: not yet recruiting.
02
Drugs
tizanidine
03
Conditions
rotator cuff tear
Beyond the preview
Go deeper on NCT05852093.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05852093.